U.S. plans to offer COVID-19 booster shots to citizens from September
Category: #healthcare  By Mateen Dalal  Date: 2021-08-18
  • share
  • Twitter
  • Facebook
  • LinkedIn

U.S. plans to offer COVID-19 booster shots to citizens from September

The Biden administration intends to start administrating COVID-19 booster doses to Americans as early as mid- or late September, depending on approval from the US Food and Drug Administration (FDA). The announcement comes as the administration struggles to reclaim control of a pandemic it claimed to have contained just over a month ago.

Health officials concluded that most people should receive a booster shot eight months after their initial vaccination. They plan to announce the decision at the White House to inform Americans that individuals who have been inoculated with Moderna or Pfizer-BioNTech vaccines require additional protection against the Delta variant.

Nursing home residents, health care employees, and emergency responders would be the first recipients of the booster shots, followed by other senior citizens and the general public. Officials plan to administer the same vaccine they initially received.

Last week, Moderna Inc. and Pfizer Inc. along with its German partner BioNTech SE received approval from US regulators for the third dose of COVID-19 vaccination for immunocompromised patients.

Officials also believe that recipients of Johnson & Johnson's vaccine, which was approved as a one-dose regimen, may require an additional dose too. Only about 14 million Americans have received the Johnson & Johnson vaccine, which the government began offering in March.

The booster plan has been in discussions for several weeks, but a final decision on the roadmap was reached recently. The administration has more than 100 million doses on hand that can be used as boosters, plus tens of millions more in pharmacies and other locations.

The authority has also ordered extra supplies, which will arrive in the fall, and officials claim they are not concerned about running out. The only concern being the data from Israel which suggests the Pfizer-BioNTech vaccine's protection has decreased dramatically for elders who received their second dose in January or February.

Source Credit –

https://news.trust.org/item/20210817043006-qv3iv/

 

About Author

Mateen Dalal    

Mateen Dalal

Despite working as a professional testing engineer, Mateen Dalal always held a liking for content creation. Following his passion, he now pens down articles for itresearchbrief.com and a couple of similar portals. Mateen is a qualified electronics and telecommunicat...

Read More>>

More News By Mateen Dalal

China: Covid-19 curbs eased in Guangzhou and Chongqing amidst protests
China: Covid-19 curbs eased in Guangzhou and Chongqing amidst protests
By Mateen Dalal

Guangzhou and Chongqing cities of China have reportedly reduced COVID-19 curbs following the clash b...

Canada to invest $708 Mn to develop new nuclear power technology
Canada to invest $708 Mn to develop new nuclear power technology
By Mateen Dalal

Canada would invest $708 million (CAD 970 million) for the development of a grid-scale small modular...

Rockefeller Foundation donates $15Mn to fight AIDS, TB & Malaria
Rockefeller Foundation donates $15Mn to fight AIDS, TB & Malaria
By Mateen Dalal

The Rockefeller Foundation has reportedly announced that it intends to donate $15 million to the Glo...